Prognostic signature of lung adenocarcinoma based on stem cell-related genes

Abstract Lung adenocarcinoma (LUAD) is characterized by high infiltration and rapid growth. The function of the stem cell population is to control and maintain cell regeneration. Therefore, it is necessary to study the prognostic value of stem cell-related genes in LUAD. Signature genes were screene...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhanghao Huang, Muqi Shi, Hao Zhou, Jinjie Wang, Hai-Jian Zhang, Jia -Hai Shi
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/7992e8314a2d45799027dee141343768
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7992e8314a2d45799027dee141343768
record_format dspace
spelling oai:doaj.org-article:7992e8314a2d45799027dee1413437682021-12-02T10:49:16ZPrognostic signature of lung adenocarcinoma based on stem cell-related genes10.1038/s41598-020-80453-42045-2322https://doaj.org/article/7992e8314a2d45799027dee1413437682021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-80453-4https://doaj.org/toc/2045-2322Abstract Lung adenocarcinoma (LUAD) is characterized by high infiltration and rapid growth. The function of the stem cell population is to control and maintain cell regeneration. Therefore, it is necessary to study the prognostic value of stem cell-related genes in LUAD. Signature genes were screened out from 166 stem cell-related genes according to the least absolute shrinkage operator (LASSO) and subsequently multivariate Cox regression analysis, and then established risk model. Immune infiltration and nomogram model were used to evaluate the clinical efficacy of signature. A signature consisting of 10 genes was used to dichotomize the LUAD patients into two groups (cutoff, 1.314), and then validated in GSE20319 and GSE42127. There was a significant correlation between signature and clinical characteristics. Patients with high-risk had a shorter overall survival. Furthermore, significant differences were found in multiple immune cells between the high-risk group and low-risk group. A high correlation was also reflected between signature and immune infiltration. What’s more, the signature could effectively predict the efficacy of chemotherapy in patients with LUAD, and a nomogram based on signature might accurately predict the prognosis of patients with LUAD. The signature-based of stem cell-related genes might be contributed to predicting prognosis of patients with LUAD.Zhanghao HuangMuqi ShiHao ZhouJinjie WangHai-Jian ZhangJia -Hai ShiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Zhanghao Huang
Muqi Shi
Hao Zhou
Jinjie Wang
Hai-Jian Zhang
Jia -Hai Shi
Prognostic signature of lung adenocarcinoma based on stem cell-related genes
description Abstract Lung adenocarcinoma (LUAD) is characterized by high infiltration and rapid growth. The function of the stem cell population is to control and maintain cell regeneration. Therefore, it is necessary to study the prognostic value of stem cell-related genes in LUAD. Signature genes were screened out from 166 stem cell-related genes according to the least absolute shrinkage operator (LASSO) and subsequently multivariate Cox regression analysis, and then established risk model. Immune infiltration and nomogram model were used to evaluate the clinical efficacy of signature. A signature consisting of 10 genes was used to dichotomize the LUAD patients into two groups (cutoff, 1.314), and then validated in GSE20319 and GSE42127. There was a significant correlation between signature and clinical characteristics. Patients with high-risk had a shorter overall survival. Furthermore, significant differences were found in multiple immune cells between the high-risk group and low-risk group. A high correlation was also reflected between signature and immune infiltration. What’s more, the signature could effectively predict the efficacy of chemotherapy in patients with LUAD, and a nomogram based on signature might accurately predict the prognosis of patients with LUAD. The signature-based of stem cell-related genes might be contributed to predicting prognosis of patients with LUAD.
format article
author Zhanghao Huang
Muqi Shi
Hao Zhou
Jinjie Wang
Hai-Jian Zhang
Jia -Hai Shi
author_facet Zhanghao Huang
Muqi Shi
Hao Zhou
Jinjie Wang
Hai-Jian Zhang
Jia -Hai Shi
author_sort Zhanghao Huang
title Prognostic signature of lung adenocarcinoma based on stem cell-related genes
title_short Prognostic signature of lung adenocarcinoma based on stem cell-related genes
title_full Prognostic signature of lung adenocarcinoma based on stem cell-related genes
title_fullStr Prognostic signature of lung adenocarcinoma based on stem cell-related genes
title_full_unstemmed Prognostic signature of lung adenocarcinoma based on stem cell-related genes
title_sort prognostic signature of lung adenocarcinoma based on stem cell-related genes
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/7992e8314a2d45799027dee141343768
work_keys_str_mv AT zhanghaohuang prognosticsignatureoflungadenocarcinomabasedonstemcellrelatedgenes
AT muqishi prognosticsignatureoflungadenocarcinomabasedonstemcellrelatedgenes
AT haozhou prognosticsignatureoflungadenocarcinomabasedonstemcellrelatedgenes
AT jinjiewang prognosticsignatureoflungadenocarcinomabasedonstemcellrelatedgenes
AT haijianzhang prognosticsignatureoflungadenocarcinomabasedonstemcellrelatedgenes
AT jiahaishi prognosticsignatureoflungadenocarcinomabasedonstemcellrelatedgenes
_version_ 1718396599426613248